Skip to main content
. 2022 Jan 15;25(1):e25870. doi: 10.1002/jia2.25870

Figure 3.

Figure 3

Cumulative incidence functions of virologic non‐suppression, loss to follow up, transfers and mortality among pregnant females 4–24.5 months from ART start.